Merck says experimental RSV treatment protected infants in trial, paving way for potential approval 0 18.10.2024 01:00 CNBC Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
